Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence

Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence

Antonios Bayas,1 Mathias Mäurer2 1Department of Neurology, Klinikum Augsburg, Augsburg, Germany; 2Department of Neurology, Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim, Germany Abstract: Multiple sclerosis (MS), a chronic demyelinating neuroinflammatory disease of the cen...

Full description

Bibliographic Details
Main Authors: Bayas A, Mäurer M
Format: Article
Language:English
Published: Dove Medical Press 2015-02-01
Series:Patient Preference and Adherence
Online Access:http://www.dovepress.com/teriflunomide-for-the-treatment-of-relapsingndashremitting-multiple-sc-peer-reviewed-article-PPA

Internet

http://www.dovepress.com/teriflunomide-for-the-treatment-of-relapsingndashremitting-multiple-sc-peer-reviewed-article-PPA

Similar Items